Literature DB >> 24144291

Neuroendocrine tumors of the gynecologic tract: select topics.

Marjan Rouzbahman1, Blaise Clarke.   

Abstract

Tumors of the diffuse neuroendocrine cell system (DNES) may arise in any component of the gynecologic tract, including the vulva, vagina, cervix, endometrium, and ovary. Overall such tumors in the gynecologic tract are rare, constituting only 2% of gynecologic cancers, comprising a spectrum of tumors of variable biologic potential. Due to the rarity of such tumors, pathologists experience may be limited and these may present diagnostic challenges. Currently the nomenclature employed is still that of the pulmonary classification systems, carcinoid, atypical carcinoid, small and large cell neuroendocrine carcinoma that broadly correlates to low/grade 1, intermediate/grade 2, and high grade/grade 3 of the WHO gastroenteropancreatic neuroendocrine tumors classification. Furthermore in keeping with the lung, proliferative rate is assessed based on mitotic index rather than Ki-67 staining. In this review we cover select neuroendocrine tumors of the gynecologic tract.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Gynecologic tract; Neuroendocrine tumors

Mesh:

Year:  2013        PMID: 24144291     DOI: 10.1053/j.semdp.2013.06.007

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  17 in total

Review 1.  Vulvar cancer: a review for dermatologists.

Authors:  Anastasiya Atanasova Chokoeva; Georgi Tchernev; Elena Castelli; Elisabetta Orlando; Shyam B Verma; Markus Grebe; Uwe Wollina
Journal:  Wien Med Wochenschr       Date:  2015-05-01

2.  Pathology of Struma Ovarii: A Report of 96 Cases.

Authors:  Shuanzeng Wei; Zubair W Baloch; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

3.  Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.

Authors:  Madhuchhanda Roy; Darya G Buehler; Ranran Zhang; Michael L Schwalbe; Rebecca M Baus; M Shahriar Salamat; Ricardo V Lloyd; Jason N Rosenbaum
Journal:  Endocr Pathol       Date:  2019-03       Impact factor: 3.943

4.  Biology and evolution of poorly differentiated neuroendocrine tumors.

Authors:  David S Rickman; Himisha Beltran; Francesca Demichelis; Mark A Rubin
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

5.  [Pregnancy-preserving and maternal-fetal management in a patient with rare large cell neuroendocrine carcinoma of the uterine cervix].

Authors:  Dai Geyang; Chen Gaowen; L I Xiaoxuan; Zheng Youhong; Wang Yuan; Li Xingsong; L I Jing; Zhou Jing; Xie Yu; Wang Yifeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-01-30

6.  Neuroendocrine Carcinoma of the Endometrium: A Clinicopathologic Study of 25 Cases.

Authors:  Cady E Pocrnich; Preetha Ramalingam; Elizabeth D Euscher; Anais Malpica
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

Review 7.  [Grading of gynecological tumors : Current aspects].

Authors:  L-C Horn; D Mayr; C E Brambs; J Einenkel; I Sändig; K Schierle
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

8.  Tumor Evolution in a Patient with Recurrent Endometrial Cancer and Synchronous Neuroendocrine Cancer and Response to Checkpoint Inhibitor Treatment.

Authors:  Nikolaos A Trikalinos; Deyali Chatterjee; Kyle Winter; Matthew Powell; Motoyo Yano
Journal:  Oncologist       Date:  2020-10-03       Impact factor: 5.837

9.  Primary mixed large cell neuroendocrine and high grade serous carcinoma of the endometrium.

Authors:  Liesel Elisabeth Hardy; Zia Chaudry; King Wan; Chloe Ayres
Journal:  BMJ Case Rep       Date:  2020-09-02

10.  Neuroendocrine Tumors of the Female Reproductive Tract: A Literature Review.

Authors:  Yi Kyeong Chun
Journal:  J Pathol Transl Med       Date:  2015-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.